对话市政协委员、华熙生物董事长赵燕：AI不只是赋能生物制造，更是产业逻辑的重塑

Core Viewpoint - The survival of future enterprises hinges on their ability to truly embrace AI, which is seen as a transformative force in the industry [2][12]. Group 1: Company Overview - Huaxi Biological is a prominent player in the biomanufacturing sector, spanning various fields including active substances, pharmaceuticals, medical aesthetics, functional skincare, and food [2]. - The company has been in the spotlight over the past year, particularly during the Fourth Session of the 14th Beijing Municipal Committee of the Chinese People's Political Consultative Conference [2]. Group 2: Industry Insights - The market for hyaluronic acid and other regenerative materials is becoming increasingly competitive, with a focus on innovation rather than mere imitation [3][5]. - The industry is shifting from single-product offerings to systemic solutions that address consumer needs, emphasizing the importance of scientific backing and social responsibility [5]. Group 3: Talent and Innovation - The transition from manufacturing to creation in biotechnology requires talent with interdisciplinary knowledge, including biology, engineering, AI, and bioinformatics [6][8]. - Attracting creative and self-driven talent in synthetic biology is a collaborative effort involving government, enterprises, and the talent pool itself [8]. Group 4: Policy and Market Transformation - Beijing has implemented policies to accelerate the innovation and market transformation of synthetic biology, demonstrating a strong governmental commitment to this sector [8][9]. - The current bottleneck in innovation lies in the tight control of early-stage intellectual property by academic researchers, which hinders collaboration with enterprises [9]. Group 5: AI's Impact on the Industry - AI is becoming a foundational capability in biomanufacturing, with companies needing to adapt their business logic and organizational structures to survive [10][12]. - The advent of AI is seen as a means to level the playing field in biotechnology, potentially leading to exponential growth through redefined innovation logic [12].